drugset / Trial / NCT05314621

A Study Comparing the Efficacy of Pataday® Once Daily Relief Extra Strength to Flonase® Allergy Relief in Subjects With Allergic Conjunctivitis

NCT05314621

Phase 4 Completed 61 enrolled Andover Research Eye Institute
RandomizedParallel-groupDouble-blindTreatment

Summary

This is a single-center, randomized, double-masked, parallel study.

Timeline

Start
2021-12-31
Primary completion
2022-07-24
Completion
2022-07-24

Drugs

EvaluationDrugModalityDoseRoute
Comparator Fluticasone propionate Other / unclassified 2 unknown Intranasal
Comparator Olopatadine Other / unclassified 1 unknown Other
Comparator Tears Naturale Unknown 1 unknown Other

Indications